Alnylam Pharmaceuticals Stock Operating Margin

ALNY Stock  USD 149.45  4.94  3.20%   
Alnylam Pharmaceuticals fundamentals help investors to digest information that contributes to Alnylam Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Alnylam Stock. The fundamental analysis module provides a way to measure Alnylam Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alnylam Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Alnylam Operating Margin Analysis

Alnylam Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
 2021 2022 2023 2024 (projected)
Other Current Liabilities494.1M585.7M713.0M748.7M
Total Assets3.6B3.5B3.8B4.0B

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Alnylam Pharmaceuticals Operating Margin

    
  (0.26) %  
Most of Alnylam Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alnylam Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Alnylam Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Alnylam Pharmaceuticals is extremely important. It helps to project a fair market value of Alnylam Stock properly, considering its historical fundamentals such as Operating Margin. Since Alnylam Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alnylam Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alnylam Pharmaceuticals' interrelated accounts and indicators.
0.93-0.10.6-0.970.750.720.960.320.910.990.960.70.430.850.980.620.820.870.83-0.130.98-0.65-0.580.77-0.86-0.890.470.92
0.93-0.440.82-0.970.630.740.910.360.990.920.940.670.260.960.90.440.910.980.63-0.470.92-0.42-0.590.93-0.74-0.950.590.99
-0.1-0.44-0.710.260.05-0.26-0.11-0.23-0.49-0.08-0.19-0.20.27-0.56-0.020.26-0.38-0.520.281.0-0.08-0.460.12-0.65-0.120.38-0.58-0.45
0.60.82-0.71-0.710.270.670.670.30.810.580.70.410.050.830.570.130.860.850.21-0.720.63-0.03-0.480.86-0.46-0.740.510.79
-0.97-0.970.26-0.71-0.77-0.76-0.95-0.38-0.96-0.96-0.98-0.67-0.33-0.92-0.97-0.53-0.88-0.92-0.780.29-0.980.550.63-0.850.850.96-0.48-0.96
0.750.630.050.27-0.770.70.720.350.630.720.750.560.270.620.790.530.460.540.850.020.75-0.6-0.420.48-0.72-0.730.230.62
0.720.74-0.260.67-0.760.70.710.180.740.730.710.480.030.80.730.210.670.770.57-0.290.74-0.52-0.160.73-0.51-0.680.470.69
0.960.91-0.110.67-0.950.720.710.350.890.940.960.710.450.820.960.630.820.850.78-0.140.96-0.55-0.710.73-0.91-0.870.440.9
0.320.36-0.230.3-0.380.350.180.350.370.30.390.320.140.340.320.170.320.310.25-0.260.31-0.25-0.440.31-0.36-0.420.170.38
0.910.99-0.490.81-0.960.630.740.890.370.90.910.690.270.970.870.430.870.970.61-0.520.89-0.38-0.560.94-0.7-0.930.640.99
0.990.92-0.080.58-0.960.720.730.940.30.90.930.690.350.860.970.540.810.880.82-0.120.97-0.68-0.540.79-0.83-0.860.510.9
0.960.94-0.190.7-0.980.750.710.960.390.910.930.670.420.850.970.630.90.870.77-0.210.98-0.52-0.710.78-0.9-0.950.350.93
0.70.67-0.20.41-0.670.560.480.710.320.690.690.670.540.630.640.680.50.630.54-0.220.63-0.29-0.460.57-0.55-0.570.630.7
0.430.260.270.05-0.330.270.030.450.140.270.350.420.540.10.410.90.220.130.460.260.38-0.25-0.340.02-0.41-0.220.070.36
0.850.96-0.560.83-0.920.620.80.820.340.970.860.850.630.10.810.260.850.980.55-0.580.84-0.35-0.480.98-0.63-0.90.680.95
0.980.9-0.020.57-0.970.790.730.960.320.870.970.970.640.410.810.610.830.830.86-0.051.0-0.68-0.620.72-0.91-0.890.340.88
0.620.440.260.13-0.530.530.210.630.170.430.540.630.680.90.260.610.380.290.630.250.58-0.33-0.490.16-0.63-0.460.090.51
0.820.91-0.380.86-0.880.460.670.820.320.870.810.90.50.220.850.830.380.90.53-0.40.87-0.37-0.60.84-0.73-0.890.330.88
0.870.98-0.520.85-0.920.540.770.850.310.970.880.870.630.130.980.830.290.90.55-0.540.87-0.39-0.50.97-0.65-0.890.660.95
0.830.630.280.21-0.780.850.570.780.250.610.820.770.540.460.550.860.630.530.550.240.82-0.82-0.440.43-0.79-0.70.210.62
-0.13-0.471.0-0.720.290.02-0.29-0.14-0.26-0.52-0.12-0.21-0.220.26-0.58-0.050.25-0.4-0.540.24-0.11-0.410.13-0.68-0.10.41-0.59-0.48
0.980.92-0.080.63-0.980.750.740.960.310.890.970.980.630.380.841.00.580.870.870.82-0.11-0.64-0.630.77-0.9-0.910.360.9
-0.65-0.42-0.46-0.030.55-0.6-0.52-0.55-0.25-0.38-0.68-0.52-0.29-0.25-0.35-0.68-0.33-0.37-0.39-0.82-0.41-0.640.1-0.260.560.42-0.07-0.37
-0.58-0.590.12-0.480.63-0.42-0.16-0.71-0.44-0.56-0.54-0.71-0.46-0.34-0.48-0.62-0.49-0.6-0.5-0.440.13-0.630.1-0.420.840.67-0.07-0.59
0.770.93-0.650.86-0.850.480.730.730.310.940.790.780.570.020.980.720.160.840.970.43-0.680.77-0.26-0.42-0.52-0.850.710.92
-0.86-0.74-0.12-0.460.85-0.72-0.51-0.91-0.36-0.7-0.83-0.9-0.55-0.41-0.63-0.91-0.63-0.73-0.65-0.79-0.1-0.90.560.84-0.520.8-0.12-0.73
-0.89-0.950.38-0.740.96-0.73-0.68-0.87-0.42-0.93-0.86-0.95-0.57-0.22-0.9-0.89-0.46-0.89-0.89-0.70.41-0.910.420.67-0.850.8-0.39-0.93
0.470.59-0.580.51-0.480.230.470.440.170.640.510.350.630.070.680.340.090.330.660.21-0.590.36-0.07-0.070.71-0.12-0.390.6
0.920.99-0.450.79-0.960.620.690.90.380.990.90.930.70.360.950.880.510.880.950.62-0.480.9-0.37-0.590.92-0.73-0.930.6
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Alnylam Pretax Profit Margin

Pretax Profit Margin

(0.25)

At this time, Alnylam Pharmaceuticals' Pretax Profit Margin is fairly stable compared to the past year.
Based on the recorded statements, Alnylam Pharmaceuticals has an Operating Margin of -0.2647%. This is 99.25% lower than that of the Biotechnology sector and 99.76% lower than that of the Health Care industry. The operating margin for all United States stocks is 95.2% lower than that of the firm.

Alnylam Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alnylam Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alnylam Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Alnylam Pharmaceuticals by comparing valuation metrics of similar companies.
Alnylam Pharmaceuticals is currently under evaluation in operating margin category among related companies.

Alnylam Fundamentals

About Alnylam Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Alnylam Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alnylam Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alnylam Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Alnylam Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1665 people.

Alnylam Pharmaceuticals Investors Sentiment

The influence of Alnylam Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Alnylam. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Alnylam Pharmaceuticals' public news can be used to forecast risks associated with an investment in Alnylam. The trend in average sentiment can be used to explain how an investor holding Alnylam can time the market purely based on public headlines and social activities around Alnylam Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alnylam Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alnylam Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Alnylam Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Alnylam Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alnylam Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alnylam Pharmaceuticals' short interest history, or implied volatility extrapolated from Alnylam Pharmaceuticals options trading.

Pair Trading with Alnylam Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alnylam Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Alnylam Stock

  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Alnylam Stock

  0.93EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.92DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.86MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.79MDWD Mediwound Downward RallyPairCorr
  0.72TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Alnylam Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alnylam Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alnylam Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alnylam Pharmaceuticals to buy it.
The correlation of Alnylam Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alnylam Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alnylam Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alnylam Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alnylam Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alnylam Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alnylam Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alnylam Pharmaceuticals Stock:
Check out Alnylam Pharmaceuticals Piotroski F Score and Alnylam Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Alnylam Stock analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.53)
Revenue Per Share
14.637
Quarterly Revenue Growth
0.312
Return On Assets
(0.05)
Return On Equity
(15.01)
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.